Recombinant Proteins Market Size, Share Report, Analysis, Trends, Growth 2030

The global recombinant proteins market size had a value of USD 1,508.99 million in 2022 and is projected to reach USD 4,298.49 million by 2030, with a compound annual growth rate (CAGR) of 13.98%.

Request Free Sample

Global Recombinant Proteins Market: Overview

Recombinant proteins are utilized for the innovation of novel therapies used in the treatment of various chronic diseases like cancer and others. Such protein production needs a special technique called recombinant DNA technology. The ongoing developments and advancements in the pharmacological sector led to the constant innovations of proteins that are used as a vital therapeutic treatment in various human diseases.

Global Recombinant Proteins Market: Growth Factors

The growing research & development activities and expenditure on biological drugs are some of the major factors expected to drive the growth of the global recombinant proteins market vigorously during the forecast period. Biopharmaceutical organizations are concentrating on innovating and launching novel biosimilars for various life-threatening diseases like diabetes, metabolic disorders, cancer, cardiovascular diseases, and several other rare conditions, like hemophilia. The rare disease medical sector accounts for the immense potential as there is very low competition. Also, the technological advancements in various fields associated with recombinant protein production further boost the growth of the global recombinant proteins market. The advanced chromatography protein purification methods like HPLC & FPLC offers highly purified clinical-grade recombinant proteins.

Moreover, the growing incidences of various chronic diseases all across the globe are further fuelling the growth of the market globally. Industries are increasingly collaborating with academic institutions in order to develop effective recombinant proteins that can help countries to reduce the growing burden of diseases all across the globe. Moreover, the growing initiatives from the government further support the growth of the global recombinant proteins market. The patent expiry of a large number of biological products is another key factor driving the growth of the market globally during the forecast period. The rising demand for personalized medicine along with protein therapeutics will create many lucrative growth opportunities in the global recombinant proteins market during the forecast period.

Recombinant Proteins Market: Report Scope

Global Recombinant Proteins Market: Segmentation

The global recombinant proteins market can be segmented into end-user, application, product, and region.

By end-users, the market can be segmented into contract research organizations, academic research institutes, biotechnology companies, pharmaceutical & biopharmaceutical companies, and others. The biologic segment accounts for the largest share in the global recombinant proteins market due to the growing prevalence of target diseases along with the development of a strong pipeline for recombinant protein-based biologics.

By application, the market can be segmented into academic research studies, biotechnological research, biopharmaceutical production, drug discovery & development, and others.

By product, the market can be segmented into additional molecule receptors, recombinant metabolic enzymes, regulatory proteins, kinase proteins, membranes proteins, structural proteins, immune response proteins, growth factors & chemokines, and others. The growth factors & chemokines segment holds the largest share in the global recombinant proteins market owing to its use in different research areas like cancer, transplant, immunology, wound healing, neurobiology, cell cultures, and several others.

Request Free Sample

Global Recombinant Proteins Market: Regional analysis

North America accounts for the largest share in the global recombinant proteins market due to the growing incidences of chronic diseases like cancer in the region. Also, the growing technological advancements in the field of recombinant proteins further boost the growth of the regional market. Also, the growing initiatives from the government to boost the research & development activities and innovate advanced therapeutic options for the treatment of chronic diseases will further propel the growth of the regional market during the forecast period.

Asia Pacific is expected to grow significantly during the forecast period owing to the fast proliferation of the healthcare sector in the region. Also, the growing investment to strengthen the healthcare infrastructures also propels the growth of the regional market. Moreover, the growing aging population along with the increasing disposable income of the people in the region will further contribute significantly towards the growth of the regional market during the forecast period.

Global Recombinant Proteins Market: Competitive Players

Some of the significant players in the global recombinant proteins market are

• Recombinant Protein
• Abnova Corporation
• GenScript Biotech Corporation
• Reprocell
• BPS Bioscience
• PeproTech
• Eurogentec
• ProSpec Tany TechnoGene
• Merck KGaA
• Lonza
• GE Healthcare
• Sigma Aldrich Company
• Thermo Fisher Scientific
• Miltenyi Biotec
• R&D Systems
• and Abcam PLC.

Global Recombinant Proteins Market: Segment Analysis

By Product

• Immune Response Proteins
• Structural Proteins
• Membrane Proteins
• Kinase Proteins
• Regulatory Proteins
• Others

By Application

• Academic Research Studies
• Biotechnology Research
• Biopharmaceutical Production
• Drug Discovery & Development
• Others

By End-User

• Contract Research Organizations
• Academic Research Institutes
• Biotechnology Companies
• Pharmaceutical and Biopharmaceutical Companies
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

What Reports Provides

• Full in-depth analysis of the parent market
• Important changes in market dynamics
• Segmentation details of the market
• Former, on-going, and projected market analysis in terms of volume and value
• Assessment of niche industry developments
• Market share analysis
• Key strategies of major players
• Emerging segments and regional markets
• Testimonials to companies in order to fortify their foothold in the market.